Acetaminophen: Nursing Drug Guide, Hepatotoxicity & NCLEX Review
Healthcare medication guide: cumulative daily dose tracking, hepatotoxicity prevention, IV medication-error safety, and overdose escalation for one of the most commonly administered analgesics.
Acetaminophen can cause dose-dependent hepatic injury, liver failure, and death when total daily intake from all routes (oral, rectal, IV) and all combination products exceeds recommended limits. The IV formulation (Ofirmev) carries a boxed warning for medication errors (mg vs mL confusion, weight-based dosing) that can cause accidental overdose. Highest-risk patients include those with hepatic impairment, chronic alcohol use, malnutrition, severe hypovolemia, and severe renal impairment (CrCl ≤30 mL/min). Nurses must calculate 24-hour totals before every dose, educate patients about hidden acetaminophen in OTC cold/flu and opioid combinations, and escalate immediately if overdose is suspected—N-acetylcysteine (NAC) is time-sensitive.
📋 Contents
⚡ Quick facts
💡 Key takeaway
Before every dose, calculate the patient’s total acetaminophen in the last 24 hours from every route and every combination product—not just the order in front of you. Exceeding the maximum daily limit can cause irreversible hepatic injury even when each individual dose looks appropriate.
Most common brand names
Acetaminophen is available as a single entity and as a hidden ingredient in hundreds of combination products. Always verify the active-ingredient list on the label or MAR—not just the brand name.
Common single-entity brands include Tylenol (oral tablets, liquids, suppositories) and Ofirmev (IV). Combination products frequently containing acetaminophen include hydrocodone/acetaminophen (e.g., Norco, Vicodin), oxycodone/acetaminophen (e.g., Percocet), butalbital/acetaminophen/caffeine (e.g., Fioricet), and many OTC cold, flu, sleep, and pain products. Duplicate therapy from unrecognized combination products is a leading cause of unintentional overdose.
Why we give it — Indications
Acetaminophen is one of the most frequently ordered analgesic and antipyretic agents in inpatient and community settings. Nurses use it for mild to moderate pain and fever reduction, often as first-line therapy when NSAID avoidance is preferred.
| Use | Detail |
|---|---|
| Mild to moderate pain | Ofirmev is indicated for mild to moderate pain in adults and pediatric patients ≥2 years, and for moderate to severe pain with adjunctive opioid analgesics. Oral OTC products are labeled for minor aches and pains (headache, backache, arthritis, toothache, muscular aches, premenstrual cramps). |
| Fever reduction | Indicated for reduction of fever in adults and pediatric patients per product labeling. Often used postoperatively, during infections, and when antipyretic therapy is ordered for fever. |
On a small screen, swipe or scroll sideways to see the full table.
How it works
Acetaminophen is a non-salicylate, non-opioid analgesic and antipyretic. The precise mechanism is not fully established but is thought to involve primarily central actions. It is metabolized in the liver via glucuronidation, sulfation, and CYP2E1 oxidation to a reactive intermediate (NAPQI). With therapeutic doses, NAPQI is detoxified by glutathione; in overdose, glutathione stores are depleted, leading to hepatocellular injury. This hepatic metabolism is why nurses must assess liver function, alcohol use, malnutrition, and concomitant CYP2E1 inducers before repeated dosing.
Dosing overview
Dosing varies by route, weight, age, and formulation. The critical nursing rule: the maximum recommended daily dose includes all routes and all acetaminophen-containing products. Dosing must be verified against current prescribing information, prescriber order, renal/hepatic function, and local policy.
Missed dose: Not specified in the reviewed prescribing information for scheduled IV use. For oral PRN orders, do not double doses; give the next dose only if the minimum dosing interval has passed and the total 24-hour maximum will not be exceeded.
Onset, peak, duration, and half-life
| Parameter | Value | Nursing relevance |
|---|---|---|
| Onset | Not specified in the reviewed prescribing information for oral formulations | Reassess pain/fever after a reasonable clinical interval; IV Cmax occurs at end of 15-minute infusion |
| Peak (IV) | Maximum concentration at end of 15-minute IV infusion | Do not repeat dose before minimum interval even if pain persists at end of infusion |
| Duration | Not specified in the reviewed prescribing information | Minimum dosing interval 4 hours (adults/children) or 6 hours (some neonatal/infant regimens) per labeling |
| Half-life | Not specified in the reviewed prescribing information for nursing-relevant summary | Hepatic metabolism; toxicity may evolve over 48–72 hours after overdose despite early absence of symptoms |
On a small screen, swipe or scroll sideways to see the full table.
Before you give it — Safety check
Pretreatment checks
- Calculate total acetaminophen received in the past 24 hours from all routes and combination products (including PRN home meds and OTC use)
- Review hepatic history (cirrhosis, hepatitis, alcohol use disorder), renal function (CrCl), nutritional status, and current warfarin or CYP2E1-inducing therapy
- Confirm allergy status, verify correct patient weight for orders under 50 kg, and for IV doses double-check mg versus mL (1000 mg = 100 mL of 10 mg/mL solution)
Contraindications
- Known hypersensitivity to acetaminophen or to any excipient in the specific formulation (IV formulation lists specific excipients including mannitol and cysteine hydrochloride)
- Severe hepatic impairment or severe active liver disease
- Do not use in patients with acetaminophen allergy; discontinue immediately at first appearance of skin rash or hypersensitivity symptoms per labeling
Important interactions
| Drug / class | Effect | Nursing action |
|---|---|---|
| Warfarin / oral anticoagulants | Chronic oral acetaminophen 4000 mg/day has increased INR in some patients stabilized on warfarin | Monitor INR more frequently with prolonged or high-dose acetaminophen; report supratherapeutic INR or bleeding signs |
| CYP2E1 inducers (e.g., chronic alcohol, some anticonvulsants) | May alter acetaminophen metabolism and increase hepatotoxic potential; ethanol also competitively inhibits metabolism | Assess alcohol use; avoid exceeding daily limits; escalate if signs of hepatic injury; verify total daily dose carefully |
| Other acetaminophen-containing products | Cumulative dosing from opioid combinations, cold/flu products, and multi-route administration causes unintentional overdose and hepatic injury | Perform medication reconciliation; teach patients to read labels; hold and clarify if 24-hour total would exceed maximum |
On a small screen, swipe or scroll sideways to see the full table.
Administration
Route: Oral (tablets, capsules, liquids), rectal suppositories, and intravenous infusion (Ofirmev 10 mg/mL). IV must be administered as a 15-minute infusion only.
- Oral: may be given without regard to food per most formulations; use only the measuring device provided with liquid products
- IV (Ofirmev): infuse over 15 minutes; for doses less than 1000 mg withdraw the ordered amount into a separate container—do not administer the entire 100 mL vial to a patient under 50 kg unless the full 1000 mg is ordered; use within 6 hours after container is opened. Follow high-alert medication administration double-check steps for IV doses.
- Do not add other medications to Ofirmev; diazepam and chlorpromazine are physically incompatible and must not be administered simultaneously
The Ofirmev boxed warning emphasizes accidental overdose from confusing mg with mL, failing to use weight-based dosing under 50 kg, pump programming errors, and not tracking cumulative daily dose. Program pumps in mg or mL only after independent double-check. Never infuse bolus IV acetaminophen.
Expected therapeutic response
- Reduction in pain score or improved patient-reported comfort within the expected timeframe for the route given
- Decrease in fever (temperature trending down) when used as an antipyretic
- Absence of sedative or respiratory-depressant effects (unlike opioid analgesics)—if somnolence or respiratory changes occur, investigate other causes or combination products
Red flags — Stop and act
Acetaminophen toxicity may present with minimal early symptoms. Late hepatic failure can develop 48–72 hours after a hepatotoxic ingestion. Escalate immediately.
- Nausea, vomiting, diaphoresis, or malaise after a known or suspected large ingestion (early overdose signs per labeling)
- Right upper quadrant pain, jaundice, dark urine, or altered mental status suggesting hepatic injury—escalate for acute liver failure evaluation
- New skin rash, mucosal lesions, blistering, or hypersensitivity (possible SJS/TEN/AGEP—rare but potentially fatal per labeling)
- Facial swelling, respiratory distress, urticaria, or anaphylaxis after IV or oral dose
- Patient or family reports exceeding maximum daily dose, combining multiple acetaminophen products, or large alcohol intake while taking acetaminophen
Adverse effects
| Adverse effect | Frequency / severity | Nursing response |
|---|---|---|
| Nausea, vomiting, headache, insomnia | Common in adult IV trials (≥5% and greater than placebo) | Monitor hydration and symptom trend; differentiate from early overdose symptoms if large cumulative dose |
| Constipation, pruritus | Common in pediatric IV trials | Supportive care; evaluate for allergic cause if pruritus with rash |
| Hepatic injury / liver failure | Serious; dose-related | Hold acetaminophen, notify prescriber, obtain LFTs and acetaminophen level, contact poison control, initiate NAC per protocol |
| Serious skin reactions (AGEP, SJS, TEN) | Rare; potentially fatal | Discontinue at first rash or hypersensitivity sign; escalate urgently |
| Hypersensitivity / anaphylaxis | Uncommon post-marketing reports | Stop infusion/dose, treat per anaphylaxis protocol, document and never rechallenge |
| AST increase, hypotension, dyspnea | Reported at ≥1% in IV trials | Monitor vitals during IV infusion; correlate with labs and clinical status |
On a small screen, swipe or scroll sideways to see the full table.
Frequency data above reflect Ofirmev clinical trial labeling. OTC adverse event rates are not specified in the reviewed prescribing information.
Overdose, toxicity, and antidote
In acute acetaminophen overdosage, dose-dependent, potentially fatal hepatic necrosis is the most serious adverse effect. Renal tubular necrosis, hypoglycemic coma, and thrombocytopenia may also occur per Ofirmev labeling.
Early signs
- Nausea, vomiting, diaphoresis, general malaise—may occur with minimal initial findings
- Clinical and laboratory evidence of hepatic toxicity may not appear until 48–72 hours post-ingestion
Antidote
N-acetylcysteine (NAC) is the antidote listed in prescribing information. Obtain serum acetaminophen assay no sooner than 4 hours after oral ingestion. Plot level on Rumack-Matthew nomogram; lower treatment line = 150 mcg/mL at 4 hours and 37.5 mcg/mL at 12 hours. Administer full NAC course if above treatment line. Obtain LFTs initially and repeat at 24-hour intervals.
Contact local poison control or medical toxicology services for overdose guidance per facility protocol. Quick medical attention is critical even when symptoms are absent (OTC labeling).
Look-alike / sound-alike and error prevention
- APAP abbreviation vs other drug abbreviations—use full name “acetaminophen” in orders and teaching when possible
- Acetaminophen vs acetylcysteine (NAC)—both used in overdose contexts; verify correct product during antidote preparation
- Acetaminophen vs aspirin (acetylsalicylic acid)—patients often say “aspirin/Tylenol” interchangeably; clarify which analgesic is ordered
- IV mg vs mL—Ofirmev 1000 mg = 100 mL; highest-risk error per boxed warning
- Combination products—hydrocodone/APAP and oxycodone/APAP look like “pain pills” but add hidden acetaminophen dose
- Duplicate therapy—scheduled IV plus PRN oral plus opioid/APAP is the most common inpatient cumulative-dose trap
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Crush/split | Institutional protocols and product formulations may vary; verify whether specific brand/formulation may be split or crushed before administration via enteral tube. |
| Food timing | Most oral formulations may be given without regard to meals per OTC labeling. |
| Enteral tube | Use liquid formulation when available; verify compatibility and flush per pharmacy if tablet must be crushed. |
| Storage | Ofirmev: room temperature; use within 6 hours after opening; do not refrigerate or freeze. |
| Lab timing | Serum acetaminophen level for overdose: no sooner than 4 hours after oral ingestion; repeat LFTs at 24-hour intervals per labeling. |
| Commonly missed | Home OTC products, nurse-administered PRN duplicates, and combination opioid tablets after scheduled IV doses. |
| Ask pharmacy when | Unclear 24-hour total, hepatic/renal adjustment needed, enteral tube administration, or suspected overdose/NAC initiation. |
On a small screen, swipe or scroll sideways to see the full table.
High-risk populations
| Population | Considerations |
|---|---|
| Hepatic impairment / chronic alcohol use | Contraindicated in severe hepatic impairment or severe active liver disease. Use caution with alcoholism, chronic malnutrition (reduced glutathione stores), and any hepatic disease. OTC labeling warns severe liver damage with 3 or more alcoholic drinks daily while using acetaminophen. |
| Severe renal impairment / hypovolemia | Creatinine clearance ≤30 mL/min: use caution with longer dosing intervals and reduced total daily dose. Severe hypovolemia (dehydration, blood loss) increases risk per labeling—monitor for acute kidney injury when renal perfusion is compromised. |
| Older adults, pediatrics, and low body weight | Geriatric patients may have greater sensitivity. Patients under 50 kg require weight-based IV dosing (max 75 mg/kg/day). Neonates and infants have lower maximum mg/kg/day limits. Always verify weight and calculate mg/kg before pediatric or IV doses. |
| Pregnancy | Published epidemiological studies with oral acetaminophen have not reported a clear association with birth defects or adverse fetal outcomes, but studies cannot definitively establish absence of risk. Animal data at clinically relevant doses showed fetotoxicity and reproductive effects. Use during pregnancy only if clearly needed and per prescriber guidance. |
| Lactation | LactMed (April 2026) states acetaminophen is a good choice for analgesia and fever reduction in nursing mothers; milk levels are much lower than typical infant doses and adverse effects appear rare. One case report described a maculopapular rash in a breastfed infant that resolved when maternal acetaminophen stopped and recurred on rechallenge. |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
Monitor
- Pain and fever response using standardized assessment such as pain assessment and temperature trends
- Signs of hepatotoxicity (RUQ pain, jaundice, nausea/vomiting, altered mental status) especially after supratherapeutic exposure; obtain liver function tests if overdose suspected
- INR in patients on warfarin receiving prolonged or high-dose acetaminophen; cumulative 24-hour dose documentation on each administration
Document
- Dose, route, time, indication, and running 24-hour acetaminophen total (especially when multiple sources exist)
- Patient weight for weight-based orders, independent double-check for IV doses, and any home/OTC acetaminophen use reported on admission or during stay
- Patient education provided on maximum daily limits, combination-product avoidance, alcohol warning, and how to access poison control or toxicology services locally for overdose
Patient teaching
- Never exceed the maximum daily amount from all products combined; many cold, flu, sleep, and prescription pain medications contain acetaminophen—read every active-ingredient label
- Do not take with other drugs containing acetaminophen unless directed by the prescriber; ask the pharmacist if unsure whether a product contains acetaminophen
- Limit alcohol while taking acetaminophen; tell your care team if you have liver disease, drink alcohol daily, or take warfarin
- Seek emergency care immediately for overdose—even without symptoms—and contact local poison control or toxicology services; quick treatment is critical
- Stop the medication and seek care for rash, blistering skin, facial swelling, or difficulty breathing
The Hold Rule
Do not give and contact the prescriber/pharmacist when:
- Known acetaminophen allergy or active hypersensitivity reaction (rash, angioedema, anaphylaxis)
- Severe hepatic impairment, severe active liver disease, or acute suspected acetaminophen toxicity/overdose
- Administering this dose would exceed the maximum 24-hour limit when all routes and combination products are included
- IV order is unclear (mg vs mL error, wrong weight-based calculation, or entire 100 mL vial ordered for a low-weight partial dose)
- New serious skin reaction or signs of anaphylaxis after a prior dose—discontinue permanently and notify prescriber per labeling
Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.
Clinical practice integration and workflow
Acetaminophen feels routine, but it causes more acute liver failure in the U.S. than any other drug class when cumulative limits are exceeded. Build total daily dose tracking into your routine medication pass, especially postoperatively when IV acetaminophen, oral PRN, and opioid combinations may run concurrently.
1. Check-before-you-give protocol
- Right patient, right drug, right dose, right route, right time—and right 24-hour total
- Scan every combination product for hidden acetaminophen (APAP) on the MAR and home med list
- For IV Ofirmev: independent double-check of mg, mL, weight, pump settings, and infusion duration (15 minutes)
- Confirm minimum 4-hour interval (6 hours in some neonatal/infant regimens) since the last acetaminophen dose from any source
2. High-alert and safety badge
Not on all institutional high-alert lists, but IV acetaminophen carries boxed-warning medication-error riskOfirmev labeling includes a boxed warning for medication errors and hepatotoxicity. Treat IV acetaminophen with the same independent double-check rigor as high-alert medications: verify mg vs mL, weight-based dosing, pump programming, and cumulative daily maximum.
3. Clinical workflow: hold and question rules
- If the 24-hour total is near or over limit, hold the dose and contact pharmacy before administration—do not rely on the patient to know their home product ingredients
- If a postoperative patient received IV acetaminophen and requests their usual Percocet or Norco, clarify whether the opioid combination is still appropriate given cumulative dose
- Escalate to poison control or toxicology and prescriber immediately for suspected overdose; do not wait for symptoms—NAC is most effective when started early
4. Critical teach-back questions
- “What is the most acetaminophen you can take in one day from all your medicines combined?” (Patient should state their prescriber or label limit—typically 3000–4000 mg/day depending on product and risk factors—and name that OTC cold/flu and prescription pain meds count toward the total.)
- “How will you check whether an OTC product contains acetaminophen?” (Patient should say they will read the active-ingredient label for acetaminophen or APAP and ask the pharmacist if unsure.)
5. Care coordination
Pharmacist: Consult for complex pain regimens, hepatic/renal dosing adjustments, interaction review with warfarin, and NAC protocol initiation for suspected overdose
Prescriber / hepatology: Notify for rising LFTs, suspected toxicity, need for alternate analgesia in severe liver disease, or serious skin reactions requiring drug discontinuation
🧠 Quick mental checklist
- What is this patient’s total acetaminophen in the last 24 hours from every route and product?
- Does this patient have liver disease, daily alcohol use, malnutrition, or CrCl ≤30?
- For IV: is this mg or mL, weight-based if under 50 kg, and infused over 15 minutes?
- Are they also receiving hydrocodone/APAP, oxycodone/APAP, or other hidden sources?
- If overdose suspected, has poison control been called and NAC pathway initiated?
Acetaminophen NCLEX practice questions
This NCLEX-style clinical judgment practice set for acetaminophen uses a tabbed inpatient case (MAR, labs, history, nursing notes), then rotates priority action, cue recognition, trend interpretation with hepatic labs, matrix urgency sorting, lab-timing judgment, and cloze antidote selection—recognise cues → analyse → prioritise → act → evaluate outcomes.
Select a tab to view MAR, labs, history, and nursing note details for this case.
- Ofirmev (acetaminophen) 1000 mg IV q6h scheduled — given 0600, 1200
- Hydrocodone/acetaminophen 5/325 mg PO q4h PRN severe pain — 1 tablet at 1300
- Acetaminophen 650 mg PO q6h PRN fever — not given
- 1400: patient requests medication for headache; no new dose documented yet
- Running 24-hour acetaminophen total (inpatient + reported home): 2325 mg at 1330
- Admission (0800): acetaminophen level not drawn; AST 22 U/L, ALT 19 U/L, INR 1.0, glucose 98 mg/dL
- Overdose pathway (if activated): level drawn at 4 h post-exposure for Rumack-Matthew nomogram; repeat AST/ALT/INR per protocol
- Example trend after exposure: acetaminophen 182 mcg/mL at 4 h (on treatment line); AST 48 → 94 U/L; ALT 52 → 118 U/L over 24 h
- 58-year-old, 68 kg, post laparoscopic cholecystectomy, day 1
- Reports 3–4 extra-strength acetaminophen tablets (500 mg each) at home in the 24 h before admission
- Social history: 2–3 alcoholic drinks nightly
- No known drug allergies
- 1300: Alert; headache 5/10; denies right upper quadrant pain or nausea
- 1330: Pharmacist message — cumulative acetaminophen approaching 4000 mg/day limit when home use is included; verify before additional doses
- 1400: Patient asks for “Tylenol” for headache; nurse reviewing MAR and history tabs before acting
Answer key & rationale
Frequently asked questions
What is the maximum daily acetaminophen dose nurses should track?
Prescription labeling for IV acetaminophen (Ofirmev) states a maximum daily dose of 4000 mg per day for adults and adolescents weighing 50 kg or more, including all routes and all acetaminophen-containing products. OTC labels warn that exceeding 4000 mg in 24 hours can cause severe liver damage. Some OTC products direct consumers not to exceed 3000 mg without physician direction. Institutional protocols and product formulations may vary.
When should a nurse hold acetaminophen and call the prescriber or pharmacist?
Hold when the patient has severe hepatic impairment or severe active liver disease (contraindicated), known acetaminophen allergy, suspected overdose, duplicate acetaminophen from combination products that would exceed daily limits, or new rash or hypersensitivity symptoms. Also hold unclear IV orders involving mg versus mL or weight-based dosing errors.
What antidote is used for acetaminophen overdose?
N-acetylcysteine (NAC) is the antidote listed in Ofirmev prescribing information. Obtain a serum acetaminophen level no sooner than 4 hours after oral ingestion, plot on the Rumack-Matthew nomogram, and administer the full NAC course if the level is above the lower treatment line (150 mcg/mL at 4 hours). Contact poison control or medical toxicology services per facility protocol and local emergency guidance.
Is acetaminophen safe during breastfeeding?
LactMed states acetaminophen is a good choice for analgesia and fever reduction in nursing mothers; milk levels are much lower than infant doses and adverse effects in breastfed infants appear rare. One case report described a rash in a breastfed infant that resolved when maternal acetaminophen was stopped and recurred when restarted.
Does acetaminophen interact with warfarin?
Ofirmev labeling reports that chronic oral acetaminophen at 4000 mg/day has increased INR in some patients stabilized on warfarin. More frequent INR monitoring may be appropriate when acetaminophen is used with oral anticoagulants, especially with prolonged or high-dose exposure.
Why is IV acetaminophen considered a high medication-error risk?
The Ofirmev boxed warning highlights risk of medication errors and hepatotoxicity from accidental overdose and death. Nurses must avoid confusing mg with mL (1000 mg = 100 mL at 10 mg/mL), use weight-based dosing for patients under 50 kg, program pumps correctly, and never administer an entire 100 mL vial to a low-weight patient when only a partial dose is ordered.
References
-
U.S. National Library of Medicine. OFIRMEV (acetaminophen) injection — Full prescribing information. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a38f63a-8852-6dab-e053-2a95a90a90d6
-
U.S. Food and Drug Administration. Prescription acetaminophen products: limited to 325 mg and updated labeling.https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-prescription-acetaminophen-products-limited-325-mg-and-updated
-
U.S. National Library of Medicine. Acetaminophen 500 mg tablet — OTC drug facts. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e817bc4a-43ef-4126-b903-aabd1390cd0c
-
Drugs and Lactation Database (LactMed). Acetaminophen. Bethesda (MD): National Institute of Child Health and Human Development; updated April 15, 2026.https://www.ncbi.nlm.nih.gov/books/NBK501194/
-
U.S. Food and Drug Administration. FDA warns of rare but serious skin reactions with acetaminophen.https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-skin-reactions-acetaminophen
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.